The Worlds #1 Renewable Energy Network for News & Information
Sign In
or
Register
Sections
Home
Solar
Wind
Geothermal
Bio
Hydro
Careers
Companies
Webcasts
White Papers
Magazines
Awards
Account
Sign In
Register
Search
REW 40 Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Amgen, Inc.
(NQ:
AMGN
)
106.38
USD
+2.14 (+2.05%)
Streaming Delayed Price
/ Updated:
12:22 PM EDT, May 22, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Amgen, Inc.
< Previous
1
2
3
4
5
6
7
8
9
...
84
85
Next >
iShares Nasdaq Biotechnology Index Fund Experiences Big Outflow
Today 11:01 EDT
Symbols mentioned in this story: IBB, REGN, AMGN, CELG Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These...
Read More
category
ETFs
from
ETF Channel
New Asthma Drug Generates Excitement For Patients -- And Its Maker
May 21, 2013
Read More
category
NYSE:MRK
,
NYSE:SNY
,
NASDAQ:REGN
, and 1 more.
from
Forbes Real Time
Lightning Round: CarMax, Asbury Automotive & More
May 20, 2013
Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites.
Read More
category
AES Corp
,
Penn National Gaming Inc/
,
MGIC Investment Corp
, and 14 more.
from
CNBC.com News
Dividend Highlights/Lowlights for May 20
May 20, 2013
These were some of the biggest dividend stock performers on the upside and the downside in today’s market action. Highlights Agnico-Eagle Mines (AEM) – up 6% Apple Inc. (AAPL) – up 3% AllianceBernstein...
Read More
category
vz
,
amgn
,
aem
, and 10 more.
from
Dividend Daily
Week in Review: RuiYi Signs Up Shanghai’s Genor to Develop mAb in China
May 18, 2013
RuiYi Inc., a San Diego-Shanghai biotech, signed an exclusive license with Genor BioPharma of Shanghai to develop RuiYi’s lead molecule in China; RuiYi also enlisted CMC Biologics to develop a cell...
Read More
from
ChinaBio® Today
Amgen-Zhejiang Beta China JV to Include R&D, Manufacturing
May 15, 2013
Last week, Amgen and Zhejiang Beta Pharma announced they would form a JV to bring Amgen’s biologic drugs to China, starting with Amgen’s colon cancer drug Vectibix. Now, an Amgen spokesperson told...
Read More
from
ChinaBio® Today
Should I Buy Pfizer? 3 Pros, 3 Cons
May 15, 2013
Read More
category
NYSE:MRK
,
Stocks to Buy
,
NYSE:PFE
, and 3 more.
from
InvestorPlace - Latest Headlines
Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest EPS Estimates For The Next Quarter
May 15, 2013
Below are the top biotechnology stocks on the NASDAQ in terms of earnings estimate for the next quarter. Biogen Idec (NASDAQ: BIIB ) is estimated to post earnings of $2.07 per share in the September...
Read More
category
Benzinga
,
Highest EPS Estimates
,
CELG
, and 6 more.
from
Latest Articles from Benzinga.com
Amgen (AMGN) - Daily Volume Review
May 14, 2013
NEW YORK (AVAFIN) -- Options traders were heavily trading call contracts during the last ...
Read More
from
AVAFIN
Short Interest in Vertex Rises, in Celgene Falls
May 11, 2013
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the latter two weeks of April. The number of shares sold short in Dendreon (NASDAQ: DNDN ), Gilead Sciences...
Read More
category
Regeneron Pharmaceuticals
,
amgen
,
Benzinga
, and 35 more.
from
Latest Articles from Benzinga.com
The Week in Review: Sagent Buys Out China JV Partner for $25 Million
May 11, 2013
Sagent Pharma, a US generic injectible drugmaker, will pay $25 million to acquire its partner’s 50% interest in a China manufacturing JV; ScinoPharm Taiwan and Coland Holdings formed a partnership to...
Read More
from
ChinaBio® Today
Ex-Div Reminder for Amgen (AMGN)
May 10, 2013
On 5/14/13, Amgen Inc (AMGN) will trade ex-dividend, for its quarterly dividend of $0.47, payable on 6/7/13. As a percentage of AMGN's recent stock price of $104.54, this dividend works out to...
Read More
category
Dividends
from
Dividend Channel
S&P Highlights Biotech ETFs
May 10, 2013
Bolstered by an accommodating Food & Drug Administration and promising recent clinical results for drugs aimed at treating conditions such as hepatitis C and multiple sclerosis, biotechnology stocks...
Read More
category
Benzinga
,
ETFs
,
PJP
, and 22 more.
from
Latest Articles from Benzinga.com
Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China
May 09, 2013
Amgen (NASDAQ: AMGN ) and Zhejiang Beta Pharma Co., Ltd. (Zhejiang Beta Pharma) today announced that the companies have signed an agreement to form a joint venture to commercialize Amgen's Vectibix®...
Read More
category
Contracts
,
Benzinga
,
AMGN
, and 1 more.
from
Latest Articles from Benzinga.com
Bull’s Eye Report: Amgen (AMGN)
May 09, 2013
Read More
category
NASDAQ:PCYC
,
NYSE:CVD
,
NASDAQ:AMGN
from
InvestorPlace - Latest Headlines
How To Profit From The Next Wave Of Dividends
May 09, 2013
Read More
category
NYSE:AVP
,
NYSE:ABC
,
NYSE:AA
, and 3 more.
from
InvestorPlace - Latest Headlines
Zhejiang Beta Pharma Forms JV with Amgen
May 09, 2013
Zhejiang Beta Pharma and Amgen will form a joint venture to commercialize Amgen's Vectibix ® (panitumumab) in China. Vectibix is a treatment for colorectal cancer. In addition to being experienced with...
Read More
from
ChinaBio® Today
Closing Bell for Wednesday on Wall Street: Markets Open Lower, Stock Prices Rise All Day
May 08, 2013
DailyFinance.com : U.S. equity markets opened lower this morning on relatively little economic data. In Europe, Germany reported that industrial production rose 1.2%, while a house price index in the...
Read More
category
dish
,
agu
,
bbby
, and 28 more.
from
DailyFinance.com
Amgen Announces Top-Line Results of Vectibix Phase 3 Head-to-Head Study Against Erbitux in Metastatic Colorectal Cancer
May 07, 2013
Amgen (NASDAQ: AMGN ) today announced that the Phase 3 head-to-head ASPECCT ('763) trial evaluating Vectibix® (panitumumab) versus Erbitux® (cetuximab) as a single agent for the treatment of...
Read More
category
Benzinga
,
AMGN
,
News
, and 1 more.
from
Latest Articles from Benzinga.com
X Factor: 5 Stocks Reaching Their Ex-Dividend Date on May 14
May 07, 2013
Microsoft, Archer Daniels Midland Company, and Marathon Oil Corporation are on the list.
Read More
category
MRO
,
MSFT
,
AMGN
, and 2 more.
from
Minyanville Headlines
IBB, AMGN, CELG, ALXN: ETF Inflow Alert
May 06, 2013
Symbols mentioned in this story: IBB, AMGN, CELG, ALXN Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These...
Read More
category
ETFs
from
ETF Channel
Amgen Has Returned 17.4% Since SmarTrend Recommendation (AMGN)
May 06, 2013
from
Comtex SmarTrend® News Briefs
Amgen (AMGN), Transgenomic Enter CE-IVD Test Development Agreement
May 06, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8306214 for the full story.
Read More
from
StreetInsider.com News Articles
Transgenomic in Collaboration Agreement with Amgen
May 06, 2013
Transgenomic, Inc. (OTC: TBIO ) today announced that it has entered into a collaboration with Amgen Inc. (NASDAQ: AMGN ) to develop a CE-IVD test to screen patients with metastatic colorectal cancer
Read More
category
Management
,
Benzinga
,
Global
, and 5 more.
from
Latest Articles from Benzinga.com
UPDATE: Monkeys Treated with Amgen (AMGN) Drugs More Likely to Survive Nuclear Attack; FDA Approves Use
May 03, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8304464 for the full story.
Read More
from
StreetInsider.com News Articles
Big drugmakers think small with nanomedicine deals
May 03, 2013
* Early-stage research but scientists see momentum building
Read More
category
companyNews
from
Reuters: Company News
UPDATE 2-Gilead profit rises, but sales of older HIV drugs dip
May 02, 2013
May 2 (Reuters) - Gilead Sciences Inc said on Thursday that its quarterly profit rose 63 percent as lower sales of its older HIV drugs were offset by strong sales of new products, but the results fell...
Read More
category
companyNews
from
Reuters: Company News
Top Fund Buys Focus On Defensive Stocks, Housing
May 02, 2013
April notched another month of gains for the stock market. That's four straight months so far this year. But this market rally is getting long in the tooth and top fund managers have been cautious in...
Read More
category
Mutual Funds
from
Investor's Business Daily - Investing RSS
Drugs from Amgen, others assessed by FDA as radiation treatments
May 01, 2013
May 1 (Reuters) - Drugs from Amgen Inc, Teva Pharmaceutical Industries and Sanofi that boost white blood cells are being evaluated by U.S. regulators as treatments for radiation exposure caused by a...
Read More
category
companyNews
from
Reuters: Company News
Illumina and Other Bargain Biotech Stocks Worth a Look Now
May 01, 2013
The research team at PropThink, which focuses on emerging growth companies in the health care sector, recently offered a list of bargain biotech stocks worth a look. The stocks that made the list...
Read More
category
SHPG
,
amgen
,
Benzinga
, and 31 more.
from
Latest Articles from Benzinga.com
< Previous
1
2
3
4
5
6
7
8
9
...
84
85
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here